Pevonedistat (PEV) + Azacitidine (AZA) Versus AZA Alone As First-Line Treatment for Patients with Higher-Risk Myelodysplastic Syndromes (MDS)/Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) with 20-30% Marrow Blasts: The Randomized Phase 3 PANTHER Trial (NCT03268954)

Mikkael A Sekeres,Larisa Girshova,Vadim A Doronin,Maria Diez-Campelo,David Valcarcel,Suman Kambhampati,Nora-Athina Viniou,Dariusz Woszczyk,Raquel De Paz Arias,Argiris Symeonidis,Achilles Anagnostopoulos,Eduardo Ciliao Munhoz,Uwe Platzbecker,Valeria Santini,Robert J Fram,Ying Yuan,Douglas V Faller,Lionel Ades

doi:10.1182/blood-2021-146154

Pevonedistat (PEV) + Azacitidine (AZA) Versus AZA Alone As First-Line Treatment for Patients with Higher-Risk Myelodysplastic Syndromes (MDS)/Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) with 20-30% Marrow Blasts: The Randomized Phase 3 PANTHER Trial (NCT03268954)

Mikkael A Sekeres, Larisa Girshova + Show 16 more

Open Access

https://doi.org/10.1182/blood-2021-146154

Copy DOI

Journal: Blood	Publication Date: Nov 5, 2021
Citations: 10

Affiliation: Sylvester Comprehensive Cancer Center, Federal Almazov North-West Medical Research Centre, City Clinical Hospital, Vall d'Hebron Institute of Oncology, Research Medical Center, Sarah Cannon, National and Kapodistrian University of Athens, Opole University, Hospital Universitario La Paz, General University Hospital of Patras, G. Papanikolaou General Hospital, Hospital Erasto Gaertner, University Hospital Leipzig, University of Florence, Takeda (United States)

#Equity Holder In Publicly-traded Company #Advisory Committees + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Pevonedistat (PEV) + Azacitidine (AZA) Versus AZA Alone As First-Line Treatment for Patients with Higher-Risk Myelodysplastic Syndromes (MDS)/Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) with 20-30% Marrow Blasts: The Randomized Phase 3 PANTHER Trial (NCT03268954)

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.